济南射精无力可以调理好吗济南阳痿是由哪些因素造成的,济南肥大前列腺,济南男人射精无力怎么解决,济南治疗阳痿早泄哪家好,济南男科医院早泄,济南男人睾丸潮湿怎么回事,济南没有早勃怎么办

The former Minneapolis police officer charged with killing George Floyd and three other officers accused of aiding and abetting in his death are scheduled to appear in court on Monday.Derek Chauvin is facing a second-degree murder charge for pinning Floyd to the ground and pressing his knee down on his neck. Floyd pleaded that he couldn't breathe, but Chauvin continued to press down for nearly eight minutes, according to bystander video.Two autopsies were performed and both ruled the death a homicide, although there were differences in what caused Floyd's death.The three other officers, J. Alexander Kueng, Thomas Lane and Tou Thao, will also appear in court Monday. Keung, Lane and Thao will appear in person, while Chauvin will appear via video conference.Their appearances are scheduled to take place around midday on Monday. Hennepin County Judge Peter Cahill has ruled that cameras cannot be present in the courtroom for pretrial hearings, though it remains to be seen if cameras will be allowed in the courtroom during the trial itself.Floyd's death prompted worldwide protests against police brutality and systemic racism. 1144

The Food and Drug Administration is investigating an outbreak of Listeria that has killed at least one person.The FDA, CDC and public health officials are looking into ten cases of Listeria monocytogenes infections reported in Florida, Massachusetts and New York. One person has died, the only available information is that the person lived in Florida.Genome sequencing of the Listeria bacteria isolated from those infected shows the ten people in this outbreak are more likely to share a common source of infection, according to the FDA. Samples were taken from patients between August 6 and October 3.In interviews with nine of the infected people, they all reported eating Italian-style meats recently, like salami, mortadella, or prosciutto, according to the FDA.Public health investigators have not found a common type of deli meat or common supplier among the patients at this time.The patients in this outbreak range in age from 40-to-89 years old, and all of them needed to be hospitalized.Listeria can cause different symptoms, depending on the person and part of the body affected, according to the Centers for Disease Control and Prevention. Symptoms include headache, stiff neck, confusion, loss of balance, fever and muscle aches. 1251

The focus of many protests going on around the country is centered around a number of topics. Social Injustice, police brutality, and, more specifically, victims of these, like George Floyd. While each topic is distinct, with its own intricacies, they generally all fall under the same umbrella of systemic racism.But what does that mean exactly?“I think of systems in play that keeps you from being great specifically because of your race,” R. Kweku Smith, a licensed psychologist said. “It’s something that holds you down in a way that appears to be invisible but has very visible results.”“It’s acknowledging the ways in which we have looked at race as part of the institutions that make up our lives,” Monique Liston, Chief Strategist at Ubuntu Research and Evaluation said. “There is no such thing as a race-neutral situation because race is so deeply embedded in what it means to live, to work, and to play. That’s what systemic racism is.”Liston has her Ph.D. in urban education. She says, as a Black woman, she experiences the effects of systemic racism regularly when people discount her expertise in the education field.“I say something about education and I have a Ph.D. in it and people will be like, I don’t think so,” Liston said of how people question her. “There is presumed incompetence, a presumed questioning. That assumption you don’t quite know what you’re talking about.”As a psychologist, R. Kweku Smith looks at the impact experiences, like the one Liston described, can impact the psyche of African Americans.“It weighs extremely heavy,” Smith said. “Part of that racial socialization, part of that talk is a speech that you have [growing up], that you have to be twice as good to get half as far. As a child, imagine the ramifications on your mind and thinking, you hear America is a place for the great, for the free, equal opportunity for all. It’s the contradiction living within it. To be in a place that’s most beautiful, the riches, all of the great things that come with America. Yet, the juxtaposition with all the ugliness that comes in, specifically the people who look [like me], it’s a hard thing to swallow.”Smith says there are examples of systemic racism in almost everything.“When you look at stillbirths, low birth rates, look at detentions and suspensions and special education,” Smith said. “Lower employment, underemployment, prison placement, early deaths. We rank high on all of those. Why is that? It’s systemic racism.”Both Liston and Smith acknowledge some people don’t believe systemic racism exists, despite pointing out the areas where African Americans are impacted disproportionately. They say, because white people don’t physically experience any of these issues on a wide scale, it’s hard to believe it’s true.“If it’s this invisible issue, you don’t have to deal with it,” Smith said. “It doesn’t seem real.”“It’s easy to acknowledge something doesn’t exist when it doesn’t affect you,” Liston said. “It’s denying air exists when I don’t see it. It’s like, OK. True. But, when I go through the science of why you’re breathing, air does exist. The same thing applies to systemic racism. The reason you’re not impacted by it is that it exists.”While Smith’s examples were some big picture issues facing people of color in health, education, and the prison system, Liston gave examples that are more personal and not as complex but still cause challenges.“People being judged by names on job applications,” Liston said. “A name similar to mine, Monique, might be something where, oh we can’t hire her. She’s not someone we’re looking for. Another one is addresses. When you have addresses on job applications, we don’t want someone represented from that neighborhood. It comes into inherently believing I’m incompetent because I'm Black.”Even daily tasks for women like Liston are impacted by systemic racism.“Is it easy for me to buy stuff for my hair at the store?” Liston said. “No. Is it easy for me to buy the makeup I want? Absolutely. If I needed something special for my hair, I had to go someplace else other than where my friends were going. It’s like the world is set up for me to be used to, not being catered to. That’s the difference. The world doesn’t cater to me and I’m used to it. The world caters to white folks and they’re used to that.”In order to better understand what systemic racism feels like, Liston gave the example of swimming.“Tell me about one of your experiences going swimming,” Liston said. “Then, someone says, no you didn’t. That’s not how it felt. That’s not what you experienced.”Liston says, that process repeats itself over and over for people of color. It can take a toll on them mentally, leaving to them feeling their experiences, opinions and really, their existence, doesn’t matter.Even though she joked around about how ridiculous some of her examples are, Liston says it causes a tremendous amount of pain for her. Humor is a coping mechanism for her but it shouldn’t be taken as a reason to further discount her experience as a Black woman.“It’s hard for white folks to reconcile that, amidst an anti-Black world, I can experience joy,” Liston said. “It’s hard to believe. Folks won’t take my story as seriously. [They’ll say], it can’t be that bad. You’re smiling. You’re happy. You’re enjoying life. It’s like, no. If I didn’t, the world would kill me.”It’s why she and Smith are so motivated to try and tear down systemic racism and make the world a more equitable place. Despite their own success, they feel an obligation to break down barriers they faced along the way to achieve that equity.“What you don’t recognize is the level of tenacity, resilience, perseverance to obstacles we have had to go through to be able to get to this point,” Smith said. “What would be the case if everyone had a truly level playing field? When you see systemic racism as a Black person who made it, you see all of your friends and families, who are just as talented as you, but maybe not as lucky to get a second or third chance. Or, maybe one of those obstacles got them in a way it didn’t get you.”In order to eliminate systemic racism and the problems it causes, Liston and Smith both just ask for empathy. To understand the white view of the world isn’t the view of every person in the world and the disadvantages they have faced are very real.“We have different ways oppression affects our lives,” Liston said. “In particular, talking to women, they can articulate what it’s like being in a male-dominated society. Let’s put race on top of that. Being able-ist. People with two arms and legs and can move about are living in a different world than folks who don’t have that. Including mental ability too. Being able to be in a space where that is questioned and adding the race question on top of that usually is the ah-ha moment for people. If it’s true here, it must be true in this circumstance as well.”In order to help, Liston suggests white people have more empathy and most importantly, believe their experiences."Follow and trust people of color, specifically Black women, when they tell you what the situation is," Liston said. "Trust it, read on it, and believe it. Then apply it to your own life. Second, unlearning and understanding what whiteness is. White folks don't do that. They want to learn about all of these culturally responsible things. Really, it's an opportunity for white folks to understand whiteness. If white people understand whiteness, the systemic racism issue can really be addressed quickly. Whiteness shapes the world we live in. Everything from the clothes we wear to what's popular on television or who is promoted at work, what names are popular this year. How the media even tells stories. Understand how whiteness was created, who was allowed to be white and how whiteness permeates society is really a great exercise for white folks to go through."This story was first reported by Shaun Gallagher at TMJ4 in Milwaukee, Wisconsin. 7976

The Daily Mail released leaked footage of the fatal Memorial Day arrest of George Floyd, who died while in the custody of Minneapolis Police.The Daily Mail did not indicate how it received the leaked body worn camera videos of the arrest. Prosecutors told CNN they are working to find the source of the leak. Several media outlets have sued prosecutors in order to gain access to the body-worn camera footage from the officers."The prosecution team is not the source of the leak. We will continue to take the strictest precautions to ensure a fair trial," Minnesota Attorney General Keith Ellison said.The Daily Mail said the footage was taken from the body cameras of Thomas Lane and Alex Kueng. Lane and Kueng along with Derek Chauvin and Tou Thao were fired as officers and criminally charged for Floyd’s death. Chauvin is facing the most serious charges, which include second-degree murder. The other three former officers are being charged with aiding and abetting a second degree murder. Chauvin was the officer that held a knee to Floyd’s neck for several minutes, leading to his death.The footage shows officers pointing weapons at Floyd in order to get him to exit his vehicle and put up his hands. The video then shows Floyd pleading with officers not to shoot him.“I'm not going to shoot you,” Lane says.The footage showed Floyd in an apparent struggle with officers as officers repeatedly asked Floyd to sit.As Chauvin laid on Floyd’s neck, Floyd could be heard telling officers, “Tell my kids I love them. I'm dead.”To view the full video, click here. 1572

The Food and Drug Administration says it is re-examining the safety of a medication that was approved despite concerns that not enough was known about the drug's risks.In response to questioning at a budget hearing last week, FDA Commissioner Scott Gottlieb told members of Congress that he would "take another look" at Nuplazid, which is the only drug approved to treat hallucinations and delusions associated with Parkinson's disease psychosis.The medication has been cited as a so-called "suspect" medication in hundreds of deaths voluntarily reported by caregivers, doctors and other medical professionals since it hit the market, as highlighted in a recent CNN report.The FDA told CNN this week that the agency had already begun conducting a new evaluation of the medication when Gottlieb was questioned about it at the hearing. The agency said the review had started several weeks ago."What does it take for a drug like this to be taken off the market?" asked US Rep. Rosa DeLauro, a member and former chair of the congressional subcommittee responsible for funding and overseeing the FDA.DeLauro pressed Gottlieb for answers on his agency's response to the safety concerns surrounding Nuplazid."How many more adverse events do we have to have reported? How many people, quite frankly, have to die? Why does the industry always take precedence over public health and safety?"Tracked by the FDA, the adverse event reports cited by DeLauro do not mean that a suspected medication has been ruled the cause of harm and are typically not the result of official investigations. But the FDA uses the information to monitor potential issues with a drug and can take action as needed: updating a medication's label, for instance, or restricting its use. In rare cases, the agency can even pull a drug off the market.When asked by CNN about what prompted the FDA's new evaluation of Nuplazid, the agency said the decision was based on a number of factors but wouldn't say what those factors were. Instead, it would only comment generally, saying that it identifies "potential signals of serious risk/new safety information" in part by using adverse event data and that the agency is not suggesting physicians stop prescribing the drug or take patients off of it while a safety evaluation is taking place.The FDA has noted that the death reports citing Nuplazid have typically involved elderly patients with advanced-stage Parkinson's disease who suffered from numerous medical conditions and often take other medications that can increase the risk of death.But physicians, researchers and other medical experts told CNN that the high number of reports deserved a closer look to determine whether they were related to the drug. They also recommended further testing of Nuplazid, worrying that the drug had been approved too quickly, based on too little evidence that it was safe or effective.Nuplazid's review was expedited by the FDA because it had been designated a "breakthrough therapy," meaning it demonstrated "substantial improvement" in patients with serious or life-threatening diseases compared to treatments already on the market.Dr. Paul Andreason, the physician who led the FDA's medical review of Nuplazid, warned that patients taking the drug during the company's clinical trials experienced serious outcomes, including death, at more than double the rate of those taking the placebo. But the FDA ruled that the potential benefits outweighed the risks, agreeing with an advisory committee that cited a lack of safe alternatives and the pleas from family members who claimed the drug was already helping or could help their loved ones.At that advisory committee meeting two years ago, one woman said that her grandmother had been part of the clinical trials for the drug and that Nuplazid had been life-changing."We didn't know what to expect or even if she was on the drug" or a placebo, said Zoey Wade. "We soon realized that she must be taking the drug, because she really returned to herself. Her hallucinations reduced, and she better understood what was real and what was imaginary."Shortly after Nuplazid's release, however, patients' family members, doctors and other health care professionals started reporting "adverse events" possibly linked to the medication -- including deaths, life-threatening incidents, falls, insomnia, nausea and fatigue.During the first 10 months Nuplazid was on the market, 244 deaths were reported to the FDA in which Nuplazid was a "suspect" medication, according to an analysis conducted by the Institute for Safe Medication Practices. FDA data now show that the number of reported deaths has risen to more than 700. In more than 1,000 reports, patients continued to experience hallucinations while on Nuplazid.After CNN published its investigation on Nuplazid, reporters were contacted by family members who said the drug helped tame hallucinations with few apparent side effects and others who said they believe Nuplazid contributed to their family member's decline or death. Some said they had not yet reported these experiences to the drugmaker or the FDA.While the FDA has long been criticized for being too slow to approve drugs, DeLauro seized on its push to streamline the process, lambasting the agency for putting industry interests and efficiency above public health and safety.DeLauro described the number of adverse events and deaths as "staggering" and "unprecedented." She also expressed concern that the drugmaker, Acadia Pharmaceuticals, is attempting to get the drug approved for a larger population: patients who suffer from dementia-related psychosis."I don't know why it should stay on the market, especially when the FDA has not determined it to be safe and while the number of adverse events continues to soar," she told Gottlieb.In response to the congresswoman's remarks, Acadia told CNN that adverse event data alone are "not a comprehensive and accurate indicator of the safety profile of any drug." In response to CNN's earlier report on the drug, Acadia said there are a number of reasons for the higher volume of death reports, including the fact that the company distributes Nuplazid through a network of specialty pharmacies that puts the company in more frequent contact with both patients and caregivers -- meaning Acadia is more likely to receive reports of death, which it is required to pass along to the FDA.Commissioner Gottlieb told the committee that the FDA is careful about the decisions it makes and that there may be a higher tolerance for risk in situations where there is an unmet medical need, "so long as the patient is properly informed of what those risks are." This echoed what he told CNN's Dr. Sanjay Gupta in an interview earlier this month.The FDA previously told CNN that it was aware of Nuplazid's "complex safety profile" at the time of approval and required the drugmaker to place warnings on its labeling. The agency also said that, though it was continuing to monitor available information about Nuplazid, it had "not identified a specific safety issue" not already reflected on the medication's label.DeLauro's office told CNN that it plans to follow up with the FDA about its inquiry into Nuplazid. 7224